Reduced-intensity radio-chemotherapy

Grant Details

Grantee Name: Dr. Alexandros Papachristofilou
Organization:
 University Hospital Basel
Country: Switzerland

Project Name:
 SAKK 01/18: Reduced intensity radio-chemotherapy for stage IIA/B seminoma
Funding Year:
 2018
Project period: 4 years

SAKK 01/18: Reduced-intensity radio-chemotherapy for stage IIA/B seminoma

The main objective of this trial is to conduct a single-arm, multicenter, prospective phase II trial testing different combinations of radiotherapy and chemotherapy based on the results of the current RTFCCR grant to reduce long-term toxicity.

icon-social-share-linkedin Created with Sketch.
icon-play Created with Sketch.
icon-download Created with Sketch.